NCT02949089View on ClinicalTrials.gov

ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Diarrhea
Interventions
DRUG

ACH04

The subjects will receive the study medication in each group

Trial Locations (1)

60160140

UNIFAC, Fortaleza

Sponsors
All Listed Sponsors
lead

Ache Laboratorios Farmaceuticos S.A.

INDUSTRY